ULTRASENSITIVE DNA EXTRACTION FROM WHOLE BLOOD
SwiftX™ Sepsis redefines rapid pathogen DNA extraction for bloodstream infection research and diagnostics, from bacteremia to fungemia
IN SEPSIS, SPEED IS SURVIVAL.
FROM DAYS TO HOURS. REVOLUTIONIZING BACTEREMIA AND FUNGEMIA DETECTION WORKFLOWS.
Culture-based identification can delay effective therapy. SwiftX™ Sepsis enables molecular detection of bacteremia and fungemia directly from whole blood within hours, supporting early pathogen identification and faster clinical decision-making.
CAPTURE. PURIFY. ANALYZE. ULTRASENSITIVE AND FAST PATHOGEN DETECTION.
SwiftX™ Sepsis (RUO) delivers pathogen DNA from whole blood in under 45 minutes, yielding PCR- and qPCR-ready DNA from bacterial and fungal targets for rapid downstream analysis.
Co-developed with academic and clinical partners, it pairs cell capture with proprietary reverse purification, enriching samples with low pathogen load and preserving low-copy targets.
View Kit and Configurations | Available Today
FASTER ANSWERS. TARGETED THERAPY. BETTER OUTCOMES.
SwiftX™ Sepsis bridges molecular research and clinical application. Once CE-IVD marked, it can support informed decisions by clinitians on optimized antibiotic and antifungal therapy long before culture-based results arrive.
Designed for Infectious Disease and AMR Research
Developed with infectious disease specialists, SwiftX™ Sepsis enables rapid, culture-free pathogen DNA extraction directly from whole blood.
Ideal for bacteremia, fungemia, and sepsis-related research, host–pathogen studies, and AMR surveillance, it accelerates molecular characterization and supports early, data-driven antimicrobial decisions.
For research use only (RUO). CE-IVD coming soon.
“SwiftX™ Sepsis empowers researchers with a fast, precise microbial DNA extraction platform in real-time.”
— Dr. Andy Wende, CEO and Head of R&D, Xpedite Diagnostics
EXPERIENCE THE DIFFERENCE
How to order
Prices and Accessories
SXFB-20
SwiftX™ Sepsis (RUO) – 20 extractions (from up to 10 mL blood)
Kit includes: Capture Beads, Lysis Buffer, Wash Buffer, Binding Buffer, Elution Buffer, Proteinase K.
399.00€
MAG-12
Magnetic separation rack for 12x 1.5mL to 2mL microtubes (MORE INFO)
Accessory for efficient use of the SwiftX™ Sepsis kit
149.50€
MAG2x50mL-LV
Magnetic separation rack for 2x 50mL tubes, for large volumes (MORE INFO)
Accessory for efficient use of the SwiftX™ Sepsis kit
259.00€
All prices without logistics costs.
COLLABORATE WITH US
We invite partners to co-validate SwiftX™ Sepsis (RUO) on clinical whole-blood samples.
Join our efforts to advance culture-free pathogen detection through: joint grant applications and pilot studies, training and SOP support, QC materials and co-authorship opportunities.
Together, we can expand sepsis research and diagnostic capacity in hospital labs, decentralized settings, and LMICs.
Explore opportunities
BROAD DOWNSTREAM COMPATIBILITY
SwiftX™ Sepsis delivers clean, inhibitor-free nucleic acids in less than 45 minutes compatible with PCR and qPCR (single-plex or multiplex).
SIMPLIFIED. AUTOMATABLE. HIGH-YIELD WORKFLOW.
Capture whole bacterial cells. Lyse. Purify. Detect. With SwiftX™ Sepsis, skip spin columns troubles.
Minimal handling, maximum recovery:
- Input: up to 10 mL whole blood
- Hands-on: <10 min
- Total time: ~45 min
- Equipment: magnetic rack, heating blocks (65 °C / 95 °C), vortexer
Automation-ready: compatible with open bench-top liquid handlers and our upcoming SwiftXtractor™ (ask us for a demo).
VALIDATED ON BACTERIAL AND FUNGAL PATHOGENS
SwiftX™ Sepsis (RUO) performance validation was carried out using clinically relevant Gram-positive, Gram-negative, and fungal pathogens, including E. coli, K. pneumoniae, S. pneumoniae, P. aeruginosa, S. aureus, E. faecalis, and C. albicans.
Paired extraction and qPCR results demonstrated consistent detection across all tested species, confirming robust yield and reproducibility from µL to 10 mL whole-blood inputs.
With optimized qPCR assays, SwiftX™ Sepsis unlocks ultra high sensitivity by enabling extraction from 10mL and detection of below 10 cfu/mL of whole blood.
SIMPLER TRAINING. ENABLING CULTURE-FREE SEPSIS RESEARCH ANYWHERE.
SwiftX™ Sepsis simplifies culture-free DNA extraction with a magnet-based workflow that requires no centrifuge or complex training. From hospital labs to decentralized research sites, it enables rapid molecular analysis directly from whole blood where speed and access are critical.
Learn More
ENVIROMENTAL FRIENDLY DNA EXTRACTION
Free from hazardous chemicals and less plastic usage, SwiftX™ Sepsis reduces environmental impact, supporting sustainable future in research and diagnostics.
SwiftX™ Sepsis Technical guides and resources
Frequently Asked Questions (FAQ)
Is the protocol instrument-free?
It is centrifuge-free and column-free. A heating block and magnetic rack are required.
Does heat lysis compromise nucleic acids?
The controlled incubations are optimized to lyse cells while preserving nucleic acids; buffer chemistry suppresses nuclease activity.
Which anticoagulants are compatible?
Validated with Na₃ Citrate; K₂ EDTA can be used. Not compatible with Li Hep.
What is the function of Beads A in SwiftX™ Sepsis?
Beads A are paramagnetic particles that capture microbial cells and white blood cells directly from whole blood, enriching pathogens while reducing host background. After lysis, they also remove cellular debris and impurities, yielding clean, inhibitor-free DNA extracts. Beads A perform both cell capture and cleanup steps.
How low can it detect?
Assay-dependent, but sensitivity demonstrated below 10 CFU/mL with standard single-copy targets.
How does Reverse Purification work?
The process, which we named “Reverse Purification”, is a true paradigm change in nucleic acid extraction. Instead of binding nucleic acids to magnetic particles, impurities such as proteins, cell debris and others are bound to our magnetic particles Beads A and extracted DNA and RNA remains untouched in the lysate. The inversion of the conventional nucleic acid purification workflow minimizes and has significant advantages as there is no loss of DNA and RNA during the extraction and purification process, which prevents reduced yields of nucleic acids.
Is SwiftX™ Sepsis for diagnostics?
No. Research Use Only (RUO). Not for use in diagnostic procedures.
SwiftX™ Sepsis. FIELD-READY PRECISION. LAB-GRADE PERFORMANCE.
SwiftX™ Sepsis bridges research and diagnostics, enabling rapid, ultrasensitive pathogen DNA extraction directly from blood — because every minute counts.
Ready to accelerate your sepsis research?
